ProMIS Neurosciences, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PMN | PRTA | ACIU | VYGR | GANX | ALEC | |
|---|---|---|---|---|---|---|
| Market cap | 31.57M | 430.72M | 227.69M | 115.23M | 48.44M | 254.58M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -0.8 | -6.4 | 3.8 | -1.5 | -1.6 | -3.1 |
| Price/book | 0.6 | 1.5 | 4.3 | 0.7 | 4.3 | -25.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −63.90% | −20.06% | −39.07% | −57.14% | −37.50% | +63.35% |
| Today | +3.23% | +2.19% | +9.57% | +2.19% | −3.48% | +11.22% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All PMN news ›ProMIS Neurosciences to Report Third Quarter 2026 Financial Results and Business Update on November 12, 2026
GlobeNewswire 03, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfol
Precision Neuroscience Corporation announced that it expects to receive $287.49983 million in funding
Precision Neuroscience Corporation announced that it will issue 39,930,532 series D preferred shares at issue price of $7.2 per share for the gross proceeds $287,499,830.4 in funding on September 11,... Precision Neuroscience Corporation…
ProMIS Neurosciences Appoints Seasoned Alzheimer’s and Neuroscience Executive Ivana Rubino, Ph.D., as Chief Commercial Officer
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.…
Precision Neuroscience Closes Oversubscribed $250M Series D Led by Pershing Square Inc., the Ackman Oxman Institute, and a Leading Life Sciences Investment Fund
Precision Neuroscience Corporation (Precision), a brain–computer interface (BCI) technology company, today announced that it has closed an oversubscribed $250 million Series D financing round, co-led ... Precision Neuroscience Closes…
[Form 3] ProMIS Neurosciences Inc. Initial Statement of Beneficial Ownership
Stock Titan - [Form 3] ProMIS Neurosciences Inc. Initial Statement of Beneficial Ownership Sentiment and the balance of points Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is
ProMIS Neurosciences awards Ivana Rubino 80,000 options
80,000 stock options go to Ivana Rubino at ProMIS Neurosciences (PMN), exercisable at $9.37. Stock Titan - [Form 4] ProMIS Neurosciences Inc. Insider Trading Activity ProMIS Neurosciences awards Ivana Rubino 80,000 options Continued…
ProMIS Neurosciences, Inc. announced that it has received $75.464029 million in funding from a group of investors
On February 3, 2026, ProMIS Neurosciences, Inc. closed the transaction. This financing was supported by a distinguished syndicate of new and existing institutional investors.... Biotechnology & Medical Research ProMIS Neurosciences, Inc.…
ProMIS Neurosciences exceeds target enrollment in Precise-AD phase 1b clinical trial
ProMIS Neurosciences Inc: ProMIS Neurosciences exceeds target enrollment in Precise-AD phase 1b clinical trial of PMN310 in Alzheimer’s disease ProMIS Neurosciences Inc - Interim analysis... Biotechnology & Medical Research ProMIS…
ProMIS Neurosciences, Inc.: Relative Strength Chart - Stock Nasdaq
Compare ProMIS Neurosciences, Inc. with the company of your choice via a Relative Strength chart. Real-time PMN price, Nasdaq stock exchange Relative Strength Chart ProMIS Neurosciences, Inc. Biotechnology & Medical Research All financial…
Chardan Initiates ProMIS Neurosciences at Buy With $20 Price Target
ProMIS Neurosciences has an average rating of buy and mean price target of $30.93, according to analysts polled by FactSet. ... Biotechnology & Medical Research Chardan Initiates ProMIS Neurosciences at Buy With $20 Price Target Published…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com5
- stocktitan.net3
- globenewswire.com2
- biospace.com1
- lincolnjournal.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.